Literature DB >> 6317831

Specificity of the involvement of chromosomes 8 and 12 in human mixed salivary-gland tumours.

G Stenman, J Mark.   

Abstract

Using the G-banding technique the chromosomal patterns in 10 in vitro-cultured human mixed salivary gland tumours were studied. When surveying the results from the present 10 adenomas together with previous results from 31 adenomas, the following characteristic features were found. Mixed tumours probably always originate with a normal diploid stemline. This stemline type was also found to predominate during progression. However, about 41% of the tumours showed abnormal stemlines characterized by highly specific, usually structural, clonal aberrations. The deviations in these abnormal stemlines seemed to preferentially affect certain chromosome types, viz. Nos. 8 and 12. This non-random pattern of deviations - not found earlier in either benign or malignant tumour types in man - indicates that certain regions of, especially, chromosomes 8 and 12 are selectively affected in mixed tumours. Among other things, changes of gene dosage and/or oncogene activation are mentioned as factors possibly influencing the characteristics of this non-random pattern.

Entities:  

Mesh:

Year:  1983        PMID: 6317831     DOI: 10.1111/j.1600-0714.1983.tb00356.x

Source DB:  PubMed          Journal:  J Oral Pathol        ISSN: 0300-9777


  2 in total

1.  Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas.

Authors:  M Nilbert; S Heim; N Mandahl; U M Flodérus; H Willén; F Mitelman
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

Review 2.  Chromosome Translocations, Gene Fusions, and Their Molecular Consequences in Pleomorphic Salivary Gland Adenomas.

Authors:  Göran Stenman; Andre Fehr; Alena Skálová; Vincent Vander Poorten; Henrik Hellquist; Lauge Hjorth Mikkelsen; Nabil F Saba; Orlando Guntinas-Lichius; Carlos Miguel Chiesa-Estomba; Mattias K Andersson; Alfio Ferlito
Journal:  Biomedicines       Date:  2022-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.